Finding 1145582 (2024-001)

Material Weakness Repeat Finding
Requirement
L
Questioned Costs
-
Year
2024
Accepted
2025-06-30

AI Summary

  • Issue: Periodic performance reports were not filed on time as required by grant guidelines.
  • Impact: This delay means we did not meet compliance requirements for reporting.
  • Next Steps: Establish controls to ensure timely preparation, review, and filing of these reports.

Finding Text

2024-001 - Filing of Periodic Performance Reports Criteria: Per the grant guidelines in State Award ID Number 724-42639/CFDA 93.959, periodic performance reports are required to be filed on a quarterly basis and are due 30 days after the quarter ends. Condition: The periodic performance reports for the year were not filed on a timely basis. Cause: Turnover in management and the accounting department delayed the filing of these reports timely. Effect: The compliance requirement for reporting was not met. Cause: Turnover in management and the accounting department delayed the filing of these reports timely. Effect: The compliance requirement for reporting was not met. Recommendation: Implement controls to ensure that the quarterly periodic performance reports are prepared, reviewed, and filed on a timely basis. Management's Response: Management agrees with this finding. See Corrective Action Plan.

Categories

Reporting

Other Findings in this Audit

  • 569140 2024-001
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $187,119
93.959 Block Grants for Prevention and Treatment of Substance Abuse $3,623